stocktools
Offerings // Estrella Immunopharma, Inc.

ESLAW offering history

Every offering-related filing in Estrella Immunopharma, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 258 filings back to Feb 19, 2021.

Last executed offering
Jan 6, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Jan 22, 2026
S-1/A — capacity, not a sale
Executed, last 12 months
2
424B pricings + 8-K 3.02 sales
Registered, last 12 months
3
S-1/S-3/F-series registrations
DateFilingWhat it means
Feb 13, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 23, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 22, 2026S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jan 16, 2026S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jan 6, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 6, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 22, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jun 3, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 19, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 17, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 12, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 9, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 27, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 18, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 2, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 21, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 6, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 2, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 15, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 11, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 7, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 16, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 12, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 28, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 28, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 18, 2023S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Nov 13, 2023S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Oct 11, 2023S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Oct 5, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 20, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 18, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 18, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 26, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 21, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 19, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 11, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 11, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 9, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 19, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 13, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
ESLAW offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ESLAW workspace →
ESLAW offering FAQ

When did ESLAW last execute an offering?

Per SEC filings, Estrella Immunopharma, Inc.'s most recent priced offering document is a 424B5 filed 2026-01-06. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ESLAW last announce or register an offering?

The most recent registration is a S-1/A filed 2026-01-22. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.